Ranbaxy Laboratories Limited (“Ranbaxy”) today announced that Atul Sobti will step down from the positions of CEO and Managing Director of Ranbaxy, effective August 19, 2010 and Arun Sawhney, currently Ranbaxy's President, Global Pharmaceutical Business, has been appointed as Managing Director, effective August 20, 2010.
Furthermore, the Board noted its sincere appreciation of Sobti’s efforts during his tenure as CEO and MD as well as for building upon the strong legacy of Ranbaxy as a premier global company.
No comments:
Post a Comment